Required section · Section 5 of 6
Your Turn: Plan the Next Step and the Message
You are handed a new case built on the same shift. The pattern is an isolated prolonged aPTT, a mixing study with partial immediate correction and worse correction after incubation, and a one-stage FVIII activity that comes back low. No chromogenic FVIII or inhibitor titer has been run yet, and medication reconciliation has not been completed. You need to decide what to order next and what you can and cannot say yet.
The decision has three parts. First, decide which additional test or check would most directly tell you whether the low one-stage FVIII reflects a real deficiency, an interference artifact, or an inhibitor. Second, recognize when a result pattern is not analytically valid, such as a nonparallel dilution series, and what that should trigger instead of a reported number. Third, decide what you can communicate now and to whom, given that an unexplained prolonged aPTT before an invasive procedure or in a new bleeding presentation calls for prompt specialist communication, while the laboratory does not choose the treatment.
Work through the ordering exercise below to put the confirmatory steps in a defensible sequence, then answer the checks that follow. Your first answer is recorded before any retry, so read the case pattern carefully before choosing.
An unexplained isolated prolonged aPTT with a low factor activity is a communication event as much as a testing event; order the workup and notify the right person without waiting for a final diagnosis you are not positioned to make.
Ordering exercise
A new specimen shows an unexplained isolated prolonged aPTT with partial mix correction that worsens on incubation. Put these confirmatory steps in a defensible working order.
1. Run the Nijmegen-modified Bethesda titer
Once a low FVIII activity is confirmed by a valid, parallel result, quantify a suspected inhibitor using the dilution closest to 50% residual activity.
2. Run one-stage FVIII activity with a parallelism check
Establish whether FVIII activity is genuinely low and whether the dilution series is analytically valid before drawing a conclusion.
3. Communicate the pattern through the critical-result and specialist escalation policy
Notify the appropriate clinician or specialist promptly once the pattern is unexplained, since the laboratory reports findings rather than choosing treatment.
4. Confirm medication history for heparin, DOAC, and emicizumab
Check for interferences that can mimic or mask a factor problem before the factor and inhibitor results are interpreted.
5. Run chromogenic FVIII activity if discordance is possible
Use a method largely insensitive to lupus anticoagulant to help separate a true low FVIII from a one-stage-specific artifact.
Knowledge checks
Reading and checks are open. Sign in only to save.
Knowledge check 1
Section status
Finish this section
Reading and checks are open. Sign in only to save.
The module finishes after every required section is marked done and every check in those sections is correct.